TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays August 16, 1974
TCL Archive President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20% February 2, 1990
